Clinical Outcomes of Melanoma Brain Metastases Treated With Stereotactic Radiation and Anti-PD-1 Therapy

被引：5
|
作者：
Ahmed, K. A. [1 ]
Stallworth, D. G. [1 ]
Johnstone, P. A. S. [1 ]
Harrison, L. B. [1 ]
Etame, A. B. [1 ]
Weber, J. S. [1 ]
Gibney, G. T. [1 ]
机构：
[1] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2015年 / 93卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2015.07.136
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
126
引用
收藏
页码：S57 / S57
页数：1
相关论文
共 50 条
  • [31] Impact of age on toxicity in patients treated with anti-PD-1 therapy for melanoma
    Shah, Kaustav P.
    Song, Haocan
    Ye, Fei
    Salem, Joe-Elie
    Balko, Justin
    Johnson, Douglas B.
    CANCER RESEARCH, 2020, 80 (16)
  • [32] Possible Interaction of Anti-PD-1 Therapy with the Effects of Radiosurgery on Brain Metastases
    Alomari, Ahmed K.
    Cohen, Justine
    Vortmeyer, Alexander O.
    Chiang, Anne
    Gettinger, Scott
    Goldberg, Sarah
    Kluger, Harriet M.
    Chiang, Veronica L.
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (06) : 481 - 487
  • [33] Imaging and Clinical Profile of Concurrent Stereotactic Radiation and Immune Therapy for Melanoma Brain Metastases
    Sloan, L.
    Lin, D. D. M.
    Shen, C.
    Redmond, K. J.
    Bettegowda, C.
    Grimm, J.
    Hoare, J.
    Link, K.
    Lim, M.
    Kleinberg, L. R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E109 - E109
  • [34] Clinical Features of Acquired Resistance to Anti-PD-1 Therapy in Advanced Melanoma
    Wang, Daniel Y.
    Eroglu, Zeynep
    Ozgun, Alpaslan
    Leger, Paul D.
    Zhao, Shilin
    Ye, Fei
    Luke, Jason J.
    Joseph, Richard W.
    Haq, Rizwan
    Ott, Patrick A.
    Hodi, F. Stephen
    Sosman, Jeffrey A.
    Johnson, Douglas B.
    Buchbinder, Elizabeth I.
    CANCER IMMUNOLOGY RESEARCH, 2017, 5 (05) : 357 - 362
  • [35] Volume of Disease as a Predictor for Clinical Outcomes in Patients With Melanoma Brain Metastases Treated With Stereotactic Radiosurgery and Immune Checkpoint Therapy
    Burke, Aidan M.
    Carrasquilla, Michael
    Jean, Walter C.
    Collins, Brian T.
    Anaizi, Amjad N.
    Atkins, Michael B.
    Gibney, Geoffrey T.
    Collins, Sean P.
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [36] Lichenoid Dermatitis in Three Patients with Metastatic Melanoma Treated with Anti-PD-1 Therapy
    Joseph, Richard W.
    Cappel, Mark
    Goedjen, Brent
    Gordon, Matthew
    Kirsch, Brandon
    Gilstrap, Cheryl
    Bagaria, Sanjay
    Jambusaria-Pahlajani, Anokhi
    CANCER IMMUNOLOGY RESEARCH, 2015, 3 (01) : 18 - 22
  • [37] The Effect of Concurrent Stereotactic Body Radiation and Anti-PD-1 Therapy for Recurrent Metastatic Sarcoma
    Callaghan, Cameron M.
    Seyedin, Steven N.
    Mohiuddin, Imran H.
    Hawkes, Kelli L.
    Petronek, Michael S.
    Anderson, Carryn M.
    Buatti, John M.
    Milhem, Mohammed M.
    Monga, Varun
    Allen, Bryan G.
    RADIATION RESEARCH, 2020, 194 (02) : 124 - 132
  • [38] The Role of Concurrent Stereotactic Body Radiation and Anti-PD-1 Therapy for Recurrent Metastatic Sarcoma
    Callaghan, C. M.
    Seyedin, S. N.
    Mohiuddin, I.
    Hawkes, K.
    Anderson, C. M.
    Buatti, J.
    Milhem, M.
    Monga, V.
    Allen, B. G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E804 - E804
  • [39] RENAL CELL CARCINOMA BRAIN METASTASES TREATED WITH STEREOTACTIC RADIATION THERAPY AND NIVOLUMAB DOES NOT ALTER LESIONAL OR CLINICAL OUTCOMES
    Mohammadi, Homan
    Tolpin, Aaron
    Figura, Nicholas
    Peacock, Jeffrey
    Oliver, Daniel
    Sim, Austin
    Palm, Russel
    Ahmed, Kamran
    Liu, James
    Nam Tran
    Etame, Arnold
    Vogelbaum, Michael
    Robinson, Timothy
    Yu, Michael
    NEURO-ONCOLOGY, 2019, 21 : 54 - 54
  • [40] Outcomes of patients with resected stage III/IV acral or mucosal melanoma treated with adjuvant anti-PD-1 therapy
    Jacques, S. K.
    McKeown, J.
    Grover, P.
    Park, B.
    Zaremba, A.
    Dimitriou, F.
    Rashid, M. F. Harunal
    Namikawa, K.
    Mooradian, M.
    Placzke, J.
    Allayous, C.
    Mehmi, I.
    DePalo, D.
    Wicky, A.
    Schwarze, J. K.
    Nakamura, Y.
    Benannoune, N.
    Menzies, A. M.
    Lo, S. N.
    Carlino, M. S.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S915 - S916
12345